Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, is today hosting the Company’s Capital Markets Day for investors, analysts and media in Stockholm, Sweden.
Orexo’s management team will expand on new strategic initiatives building upon the Company’s strong financial and operational foundation, primarily driven by the performance for Zubsolv® in the US. The event will highlight the Company’s plans to further strengthen its pipeline and innovative formulation technologies. In addition, management will also elaborate on efforts to broaden the commercial platform to leverage scale and expand sales through business development and potentially M&A transactions.
With a highly positive outcome in the recent patent litigation concerning Zubsolv, Orexo’s core asset has received strengthened IP in the US until 2032. The decision has enabled Orexo to continue with its strategy to maximise Zubsolv´s potential in a fast growing US market. The team will also expand on the latest market trends and demonstrate how it intends to further strengthen its market position.
The event will be moderated by Charlotte Stjerngren, former news anchor for Börslunch, where members of the Orexo management team including among others Nikolaj Sørensen, CEO and President, Robert DeLuca, President US Inc., Johannes Doll, EVP and Head of Corporate Development, and Martin Nicklasson, Chairman of the Board of Directors will be presenting. The Keynote speaker is former New Jersey governor, Chris Christie, who will be discussing the current landscape of the opioid crisis, and how to combat it.
All presenters during the Orexo Capital Markets Day
- Martin Nicklasson, Chairman of the Board of Directors, Orexo
- Nikolaj Sørensen, CEO and President, Orexo
- Dan Hawkins, Founder & Managing Director, Clarion Healthcare
- Robert A. DeLuca, President, Orexo US Inc.
- Joseph DeFeo, EVP and Chief Financial Officer, Orexo
- Fred Nyberg, PhD, Professor, Division of Biological Research on Drug Dependence, Uppsala University
- Johannes Doll, EVP and Head of Corporate Development, Orexo
- Michael Sumner, Chief Medical Officer, Orexo
- Robert Rönn, Head of Pharmaceutical Development and IP, Orexo
- Chris Christie, Former Governor of New Jersey and former Chairman of the US President’s Commission on Combating Drug Addiction and the Opioid Crisis
The meeting will be held at the Armémuseet, Riddargatan 13, Stockholm, Sweden. The event will start at 12:00 noon CET with a networking lunch, followed by presentations commencing at
1:00 pm CET.
A live webcast will be available on the Orexo website and questions related to the presentations can also be sent to ir. A replay of the event and presentation slides, excluding Chris Christie´s performance, will be made available shortly after.
Innovate and Win the Future through Intelligence, P-MEC China 2019 to “Set Sail” Intelligently
The National Medical Products Administration of China officially issued the Guiding Opinions on Building Information Technology-Enabled Drug Traceability Systems in Nov. 2018. The introduction of this Guiding Opinions marks the return of the drug traceability system after the electronic supervision code system was halted in 2016. Tracking and source tracing of information in pharmaceutical production, circulation, and use, etc. through information-technology-enabled means to form an organic whole will become a development trend of the industry in the future. Chinese pharmaceutical enterprises have attached greater importance to the improvement of enterprise information management as successive favorable policies are introduced.
P-MEC China 2019, a grand international party for the industry exchange and cooperation, and common development in the pharmaceutical field that is hosted by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and UBM EMEA and co-sponsored by Shanghai UBM Sinoexpo International Exhibition Co., Ltd. (UBM Sinoexpo), will “set sail” intelligently on June 18-20, 2019 at Shanghai New International Expo Centre. The exhibition will further upgrade and optimize the Pharma Automation & Information Zone first launched in 2018 – it will be located in Hall N1 to co-locate with global leading pharmaceutical equipment manufacturers. The “Automation and Informatization Forum” will also be held concurrently, to provide pharmaceutical enterprises and pharmaceutical equipment enterprises with an efficient platform for display, exchange, cooperation, and learning.
To help the Chinese pharmaceutical producers welcome the new era of intelligent production
Tang Jiliang, a former researcher of Shanghai Institute of Pharmaceutical Industry, said in an interview, “The real intelligent manufacturing can effectively shorten product development, increase production efficiency, improve product quality, and reduce resource and energy consumption. All those advantages are what traditional pharmaceutical industry lacks and urgently needs. In the coming years, intelligent manufacturing will become a development trend of the global pharmaceutical industry that serves as a part of the manufacturing industry.”
P-MEC China is a prestigious event of the pharmaceutical engineering and machinery industry in China and Asia-Pacific region. The host, in order to accurately show the current situation of pharmaceutical automation and informatization in China and assist pharmaceutical enterprises to achieve compliant and efficient development, will make every effort to increase promotion of the Pharma Automation & Information Zone in 2019, so as to attract industry top enterprises to join. The zone will cover three aspects: system integration (providing overall project solutions and implementation schemes), automatic products (robots, manipulators, mechanical transmission products, AGV automatic logistics equipment and systems, mechanical lifting and handling equipment, packaging and sorting products, sensors, controllers, inverters, and instruments and valves, etc.), and information system (MES, ERP system, cGMP management system, CaaS, IDC-internet data center, and industrial big data service), to give visitors a close look at the leading techniques in the global intelligent manufacturing field.
To focus on the pharmaceutical intelligent manufacturing and achieve upgrading and transformation of traditional industry
Besides the product display, there will be a 1.5-day “Automation and Informatization Forum” held in the Pharma Automation & Information Zone, to directly touch upon core elements of pharmaceutical intelligent manufacturing. The host will invite international top technology providers and representatives of Chinese leading pharmaceutical enterprises, to share and discuss the most popular information applications presently in use as well as automatic production process upgrading, bringing visitors a deluge of intelligent knowledge. The forum will cover fascinating topics including “Multi-place Coordinated Production of Pharmaceutical Enterprises based on Digitalization and Informatization”, “From R&D to Production–How to Largely Increase Efficiency through Transparent and Complete Information Data”, “A Focus on Pharma 4.0–What Do We Lack for Achieving Intelligent Pharma?”, and “How to Achieve Robustness Improvement of the Production Process through Perfection of Data Integrity”.
What P-MEC China 2019 will bring is not only the application of global intelligent technology in the pharmaceutical industry, but also an important step in leading the Chinese and even Asian pharmaceutical industry towards comprehensive intelligent manufacturing.
For more information, please visit the official website: http://en.pmecchina.com/
CSA Medical’s truFreeze® Spray Cryotherapy Highlighted at New York Society for Gastrointestinal Endoscopy Annual Me eting 2018
Spray Cryotherapy Ablation procedure shared “live” and in real time demonstrates the use of Rapid AV Catheter in Esophageal Cancer
CSA Medical announced the first live case highlighting the use of the company’s truFreeze® Spray Cryotherapy in a patient with esophageal cancer that was performed yesterday during a Live Case presentation at the 42nd Annual New York Course of the New York Society for Gastrointestinal Endoscopy (NYSGE). Vanessa M. Shami, MD, professor of gastroenterology at the University of Virginia Medical Center, successfully performed the procedure which was streamed live on December 13, 2018.
truFreeze utilizes the extreme cold of liquid nitrogen (-196 C) to ablate diseased tissue, including cancer, causing instant cell death. Together with a 16 Fr. CryoDecompression Tube, clinicians are able to get into constricted spaces, a characteristic of esophageal cancer. Moreover, truFreeze does not require the catheter to touch the tissue, enabling the treatment of nodular disease and unique morphologies.
“The inability to swallow and eat a normal diet significantly decreases the quality of life for patients with esophageal cancer, and can result in malnutrition,” said Dr. Shami. “I recommend spray cryotherapy ablation to many of my esophageal cancer patients because it penetrates deeper than other ablation therapies without the scarring and post-procedural pain associated with radiofrequency burning or balloon ablation. The ability to perform the procedure as an outpatient therapy that allows patients to go home the same day provides significant quality of life benefits to a population that may be suffering from a range of health challenges.”
The patient, in his 90s, had a recurrent tumor and is not a candidate for surgery. He opted for spray cryotherapy ablation of the tumor based on data demonstrating that this approach could improve his ability to swallow and eat a more normal diet without the foreign body sensation associated with stents. To date, the patient has undergone two treatments approximately one month apart and was able to return home the same day without the need for narcotics. Additionally, he did not report any noticeable side effects following each procedure.
“truFreeze spray cryotherapy is rigorously tested and widely adopted and is the only FDA-cleared therapy proven to treat the entire esophageal disease spectrum, including esophageal cancer. For the patient, there is also data that supports spray cryotherapy resulting in less pain than other ablative therapies,” said Wendelin Maners, CSA’s President, truFreeze Business. “Dr. Shami’s live procedure underscored not only truFreeze’s ease of use, but also the important quality of life improvements that spray cryotherapy can achieve for this patient population. We hope that today’s demonstration will remind gastroenterologists to incorporate truFreeze into their treatment algorithm for both Barrett’s esophagus and esophageal cancer patients.”
Sun Nuclear Releases 1028 XP Continuous Radon Monitor
Sun Nuclear Corporation, a leading provider of Continuous Radon Monitors (CRMs) for commercial and residential purposes, today announced release of the 1028™ XP Continuous Radon Monitor. The 1028 XP is the latest offering from the Sun Nuclear Radon Detection product line.
The 1028 XP Monitor takes the trusted technology of the Model 1028™ CRM and expands on it with a full-color graphic display for comprehensive review of data and test results, an extended battery life of up to 300 hours, and 10,000 datapoints in up to 10 test memory slots. Its Bluetooth connectivity to the OneRADON reporting software, make it a great solution for radon professionals on the go.
“We’re excited to offer this new Monitor to our customers, based on the trusted technology of our Model 1028 monitor,” said Dr. Kai Wundke, Sun Nuclear’s Senior Director, Radon. “The modern, functional design and easy-to-use interface combined with its expandable capabilities make it a smart investment for radon professionals.”
A future, modular upgrade to the 1028 XP and OneRADON Software will support cellular communication for remote operation and cloud connectivity. It will also support environmental monitoring of Volatile Organic Compounds (VOCs), Carbon Dioxide, temperature, pressure, and humidity.
In addition to this new Monitor, Sun Nuclear offers Model 1027™, Model 1028™, and Model 1030™ CRMs for professional home and building inspectors. The Model 1030 recently received National Radon Safety Board (NRSB) approval.
About Sun Nuclear Corporation
In addition to providing leading Radon Detection solutions for commercial and residential purposes, Sun Nuclear is the worldwide leader in Patient Safety solutions for Radiation Oncology. We design and manufacture devices and software to ensure radiation prescriptions are accurately and consistently delivered to cancer patients. We hold numerous patents for groundbreaking product designs, and distribute solutions globally, both directly and through a network of 60+ distributors. Gammex, a leader in patient alignment technology and QA tools for the diagnostic radiology field, is a wholly-owned subsidiary. Visit us: sunnuclear.com. Follow us: @SNC_Radon.
Subscribe to PICANTE via Email
Follow us on Facebook
ZEE5 and Dialog Announce a Strategic Partnership to Bring the Largest Bouquet of Premium Regional Content to Sri Lanka
Excitech to Deliver Common Data Environment to Heathrow Airport Limited
The “Calligraphy, Tea Culture and Silk Road Photography” Sino-Singaporean cultural exchange event takes place in Singapore
Polystar’s Enhanced 5G Core Network Testing Capabilities Help CSPS on Road to Commercial Deployment
LGT opens wealth management office in Thailand for high net worth investors
Nielsen Launches SMARTSTORE in Hong Kong
Statement by Commissioner Jourová ahead of the European Day for Victims of Crime
Structure of orchards in 2017 – Two-thirds of the EU’s fruit plantation area is concentrated in Spain, Italy and Poland
State aid: Commission opens in-depth investigation into British Capacity Market scheme
MYCOM OSI Demonstrates End-to-End Assurance for Red Hat virtual central office solution
Federal Signal Announces Plans to Expand Illinois Manufacturing Facility to Support Increased Demand
Indonesian Digital Infrastructure Provider Alterra Deploys Vymo Sales CRM to Grow Channel Partner Business
University of New Haven Researchers Discover Critical Vulnerabilities in Popular Virtual Reality Application
VRtuoso Secures $650,000 to Extend VR Enterprise Training to All Companies
NexTech Launches ‘Try-It-On’ Augmented Reality Experience for Online Retail
Belfast Tech Startup Using Automated Lip-Reading to Make User Authentication Systems More Resistant to Spoofing Attacks
The BBVA Foundation recognizes Ivan Sutherland for revolutionizing human-machine interaction through computer graphics and virtual reality
Best New Automotive Innovations for 2019 Announced by Automobile Journalists Association of Canada
Cipla and Wellthy Therapeutics Announce Partnership to Offer Digital Therapeutics for Diabetes and Cardiovascular Diseases
Seismic Named to Fast Company’s Annual List of the World’s Most Innovative Companies
Karma Automotive Bolsters Growing Leadership Ranks
Vibes Unveils Conversational Analytics, The Industry’s First Natural Language Processing Solution
New Study: 7 in 10 women make significant financial sacrifices for the sake of others
BizClik Media Announces the Launch of FinTech Magazine
Infosys Recognized Among the Top Three Employers in Europe and Middle East
Rolls Royce and Tudor Tech sign up to the Defence Aviation Safety Conference
Alfred Street Baptist Church Awards Howard University $100K To Pay Off Student Tuition and Fee Balances
The HistoryMakers Kicks Off Black History Month on PBS
David Beckham’s luxury men’s grooming brand HOUSE 99 is celebrating its first anniversary
Wirecard Enables Mobile Payments via Alipay at Stockmann, the Leading Luxury Fashion Department Store Chain in the Baltics
TrueCar Receives Two “Top Rated” DrivingSales Dealer Satisfaction Awards
750,000+ Celebrate the Future of the Mobility Industry at 2019 NAIAS
Gubagoo Wins “Top Rated” DrivingSales Dealer Satisfaction Award for Fourth Consecutive Year
Plant-Based Foods of Canada Welcomes Canada Food Guide Focus on Plant-based Proteins
Spotlight Labs Introduces SPYDR® Hypoxia Sensor Device
Global campaign offers Pope Francis $1 million to try vegan for Lent to save the planet
Adventure Awaits At Upscale Boutique Hotel Near Rocky Mountain National Park
Mytaste Group AB signs agreement with, igaming affiliate supplier voonix.net
Don Morphy Wins 2019 Fashion Group International Rising Star Award In Menswear
Sentry Energy Solutions Acquires Himarc Environmental Solutions
The Power Of The Bagel: Go Dairy-Free At Einstein Bros. Bagels
Emmy Nominated, National Geographic filmmaker joins blockchain group PO8
Malta AI & Blockchain Summit throwing massive show in May
Grand Opening of Unique Temple in India
Show The World Who You Are
Corcentric Named a Leader in IDC MarketScape Worldwide SaaS and Cloud-Enabled Accounts Payable Applications 2019
Frist Art Museum introduces “Dorothea Lange: Politics of Seeing”
Kaon Interactive Named Top ten provider of sales technology solutions
IoT Forum Africa 2019 to Showcase Latest Innovations in IoT
Chris Evans, new Virgin Radio DJ, looks to follow up his success of CarFest with the launch of RunFestRun
Follow our Tweets
European Commission Press Releases6 days ago
Digital Single Market: EU negotiators agree to set up new European rules to improve fairness of online platforms’ trading practices
Latest News6 days ago
T-Mobile Austria deploys TEOCO’s SmartCM to improve network operations
Banking & Financial Service6 days ago
Bitstop Unveils Next Generation Bitcoin ATM at EuroCIS Conference
European Commission Press Releases6 days ago
Digital Single Market: EU negotiators reach a breakthrough to modernise copyright rules
Automotive3 days ago
More than 200 Unifor activists storm Canadian Auto Show
Asia6 days ago
OKEx Revisited Bangkok After Launch of Thai Baht Trading
Computer Electronics6 days ago
Lead5 Exposes Hidden Executive Jobs, Opening New Doors for Talented Executives
Italy3 days ago
Exprivia | Italtel Debuts First Blockchain-Based Solution for Number Portability